AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Co-Diagnostics, Inc. Common Stock
XNAS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG004HTR2F9
0.55▼ 0.02 (-4.30%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
0.57
Day's Range
0.53 – 0.57
52-Week Range
0.17 – 13.54
Volume
282.7K
Avg Volume
384.1K
Share Statistics
Shares Outstanding
Employees
115
Exchange
XNAS
Listed
2017-07-12
Share count as of August 11, 2026

Co-Diagnostics, Inc. Common Stock (CODX) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Co-Diagnostics, Inc. Common Stock (CODX)
What is Co-Diagnostics, Inc. Common Stock's Market Cap?
Co-Diagnostics, Inc. Common Stock's Market Cap is $3.4M, based on as-reported figures from SEC (XBRL) filings.
What is Co-Diagnostics, Inc. Common Stock's Enterprise Value?
Co-Diagnostics, Inc. Common Stock's Enterprise Value is -$239.0K, based on as-reported figures from SEC (XBRL) filings.
What is Co-Diagnostics, Inc. Common Stock's Price / Sales?
Co-Diagnostics, Inc. Common Stock's Price / Sales is 4.7×, based on as-reported figures from SEC (XBRL) filings.
What is Co-Diagnostics, Inc. Common Stock's EV / Revenue?
Co-Diagnostics, Inc. Common Stock's EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Co-Diagnostics, Inc. Common Stock's EV / EBITDA?
Co-Diagnostics, Inc. Common Stock's EV / EBITDA is 0.0×, based on as-reported figures from SEC (XBRL) filings.
What is Co-Diagnostics, Inc. Common Stock's Revenue (TTM)?
Co-Diagnostics, Inc. Common Stock's Revenue (TTM) is $721.4K, based on as-reported figures from SEC (XBRL) filings.
What is Co-Diagnostics, Inc. Common Stock's Net Income (TTM)?
Co-Diagnostics, Inc. Common Stock's Net Income (TTM) is -$47.1M, based on as-reported figures from SEC (XBRL) filings.
What is Co-Diagnostics, Inc. Common Stock's EBITDA?
Co-Diagnostics, Inc. Common Stock's EBITDA is -$48.0M, based on as-reported figures from SEC (XBRL) filings.
What is Co-Diagnostics, Inc. Common Stock's Diluted EPS (TTM)?
Co-Diagnostics, Inc. Common Stock's Diluted EPS (TTM) is -7.53, based on as-reported figures from SEC (XBRL) filings.
What is Co-Diagnostics, Inc. Common Stock's EBITDA Margin?
Co-Diagnostics, Inc. Common Stock's EBITDA Margin is -6650.1%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · CODXAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth+2.0%+190.3%+76.7%-77.3%
Cost of Revenue
Gross profit
% of revenue72.7%-32.8%46.0%81.9%
Operating expenses
Selling, General and Administrative Expense
Research and Development Expense
Depreciation Expense
Total operating expenses
% of revenue3805.2%6276.4%10102.7%4906.4%
Loss from operations
% of revenue-3732.5%-6309.1%-10056.7%-4824.5%
Other income (expense), net
Interest Income
Non-Operating Income (Expense)
Gain (loss) on remeasurement of acquisition contingencies
Total other income (expense), net
Loss before income taxes
Income Tax Expense
Net loss
% of revenue-3782.4%-6262.3%-9755.1%-4049.3%
Earnings Per Share (Basic)—
Earnings Per Share (Diluted)—